Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Similac Formula Lawsuit Filed By Mother of Premature Baby Diagnosed with NEC, Left with Short Bowel Syndrome The baby was fed Similac for several days before developing NEC, resulting in the need for multiple surgeries and causing permanent injuries. January 18, 2022 Irvin Jackson Add Your Comments The mother of a premature infant alleges in a recently filed lawsuit that side effects of Similac caused necrotizing enterocolitis (NEC) shortly after the cow’s milk formula was fed to her baby in the NICU. The complaint (PDF) was brought by DaNitra Rhodes in the U.S. District Court for the Northern District of Illinois on January 14, alleging Abbott Laboratories knew about the risks associated with their Similac formula, yet continued to promote it as safe for premature infants. Rhodes is the mother of Kingston Grisby, referred to as “Baby Kingston” in the lawsuit, who was born prematurely in April 2015 and fed Similac formula while in the neonatal intensive care unit (NICU) at the Dallas hospital where he was born. The lawsuit alleges that Baby Kingston developed NEC from Similac formula, which is based on cow’s milk instead of human breast milk. “Significantly higher rates of NEC have been found in premature or preterm babies with low birth weights who are fed cow’s milk-based formula or fortifier products,” according to the Similac formula lawsuit. “The companies who manufacture these products often intentionally mislabel and misrepresent the contents of the products both to the public at-large and to the health care community, passing off these deadly products as something similar to or even superior to human breast milk.” BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Baby Kingston, who was born at 26 weeks, was first actually fed his mother’s breast milk for nearly a month, according to the lawsuit. However, he was fed Similac Neosure preterm formula for six days in May 2015, while still in the NICU, and suddenly developed severe complications. “On May 28, 2015 at 1:00 AM, Baby Kingston’s feeds were stopped due to recurrent episodes of vomiting and a significant increase in his abdominal girth,” the lawsuit notes. “Baby Kingston was diagnosed with NEC on May 28, 2015 and was forced to undergo an exploratory laparotomy, resulting in the resection of half of his small intestine and the placement of an ostomy.” The Similac formula lawsuit notes the child required multiple surgical treatments, leaving him with short bowel syndrome. As a result, the child is underweight, suffers incontinence, and will require gastrointestinal care for the rest of his life. NEC Risk for Premature Babies Fed Similac Formula Studies have shown that cow’s milk formula products like Similac and Enfamil cause NEC at substantially higher rates than is seen among premature babies fed breast milk or donor milk alone. However, the lawsuit maintains that Abbott Laboratories failed to provide adequate warnings or instructions about the risk. In a study published in November, Canadian researchers warned that preterm and low birth weight infants given cow’s milk-based formula were three times as likely to be transferred to a neonatal intensive care unit (NICU) for suspected NEC than those given donor milk. Similar findings were published in October in the medical journal Nutrients, which found that breast milk was the “gold standard” for nutritional support during infancy, with antimicrobial and bioactive factors which helped prevent NEC. Rhodes’ complaint joins a growing number of baby formula NEC lawsuits now being brought by families nationwide, each raising similar factual allegations and claims, indicating that marketing by the manufacturers caused these formulas to displace breast milk that infants would have otherwise received, robbing them of a primary defense against NEC. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Abbott Laboratories, Infant Death, Infant Formula, Necrotizing Enterocolitis, Preterm Birth, Similac Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Abbott Seeks Federal Protection From Similac NEC Lawsuits December 16, 2025 Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025 Similac Lawsuit Claims Infant Formula Side Effects Led to Preemie’s Death October 27, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 2 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025) Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: 3 days ago) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025) Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 4 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)
Similac Formula NEC Lawsuits Selected for Bellwether Trials in Aug. 2026, Nov. 2026 and Feb. 2027 November 11, 2025
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: 2 days ago) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: 3 days ago) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)
Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 4 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)